Hinge Health, Inc.（HNGE）今日盘中股价大幅上涨5.06%，引发市场广泛关注。
消息面上，公司近期多项利好持续催化：摩根士丹利将目标价从72美元大幅上调至108美元，并维持"增持"评级；一项临床研究显示，其跌倒预防项目使65岁以上人群跌倒次数减少37%、急诊就诊几率降低57%，凸显了公司在数字肌肉骨骼护理领域的技术优势。此外，公司此前已将全年营收指引上调至8.18亿至8.24亿美元，高于分析师预期的8.016亿美元，市场对公司即将发布的Q2财报充满期待，一致预期本季度营收约2.01亿美元，同比增长60.38%，调整后每股收益0.59美元，同比增长582.69%。
Hinge Health是一家AI驱动的数字肌肉骨骼护理平台，通过可穿戴设备和专业临床团队提供从急性损伤到术后康复的全流程服务，在行业内具备较强的竞争优势与成长潜力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.